Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,720 | 2 | 55.0% |
| Consulting Fee | $2,610 | 1 | 38.6% |
| Food and Beverage | $401.61 | 6 | 5.9% |
| Travel and Lodging | $35.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,610 | 1 | $0 (2024) |
| Aadi Bioscience, Inc. | $2,055 | 1 | $0 (2024) |
| Deciphera Pharmaceuticals Inc. | $1,931 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $130.51 | 2 | $0 (2024) |
| PFIZER INC. | $39.70 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,651 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,610) |
| 2023 | $39.70 | 2 | PFIZER INC. ($39.70) |
| 2022 | $76.23 | 1 | Daiichi Sankyo Inc. ($76.23) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Honoraria | Cash or cash equivalent | $1,665.00 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Food and Beverage | In-kind items and services | $115.70 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Food and Beverage | In-kind items and services | $115.70 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2024 | Daiichi Sankyo Inc. | Turalio (Drug) | Food and Beverage | In-kind items and services | $54.28 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2024 | Aadi Bioscience, Inc. | — | Honoraria | Cash or cash equivalent | $2,055.00 | General |
| 01/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,610.00 | General |
| 09/29/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2022 | Daiichi Sankyo Inc. | Turalio (Drug) | Food and Beverage | In-kind items and services | $76.23 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 326 | 551 | $352,668 | $59,208 |
| 2022 | 6 | 286 | 463 | $322,350 | $53,801 |
| 2021 | 5 | 218 | 343 | $256,040 | $39,911 |
| 2020 | 4 | 162 | 272 | $127,234 | $22,240 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 57 | 168 | $116,327 | $21,548 | 18.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 63 | $53,933 | $7,722 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 80 | $49,688 | $6,797 | 13.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 33 | $24,981 | $5,118 | 20.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $18,962 | $4,803 | 25.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 42 | $15,546 | $4,607 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 48 | 62 | $28,472 | $3,314 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 33 | $23,172 | $2,981 | 12.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 40 | $21,587 | $2,318 | 10.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 55 | 150 | $115,906 | $19,129 | 16.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 68 | $61,624 | $8,622 | 14.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 38 | 38 | $26,152 | $6,228 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 55 | $33,180 | $4,945 | 14.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $15,926 | $4,145 | 26.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 41 | $15,088 | $3,823 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 36 | $17,052 | $2,084 | 12.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $13,052 | $2,024 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $14,956 | $1,799 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 18 | $9,414 | $1,002 | 10.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 34 | 64 | $54,234 | $8,783 | 16.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 50 | $45,300 | $6,885 | 15.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 38 | 38 | $34,402 | $6,411 | 18.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 35 | 60 | $37,320 | $5,061 | 13.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 50 | $35,600 | $4,416 | 12.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $11,844 | $3,331 | 28.1% |
About Dr. Nam Bui, MD
Dr. Nam Bui, MD is a Medical Oncology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982994802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nam Bui, MD has received a total of $6,767 in payments from pharmaceutical and medical device companies, with $6,651 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Honoraria" ($3,720).
As a Medicare-enrolled provider, Bui has provided services to 992 Medicare beneficiaries, totaling 1,629 services with total Medicare billing of $175,160. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Stanford, CA
- Active Since 04/12/2011
- Last Updated 04/16/2024
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1982994802
Products in Payments
- VIMSELTINIB (Drug) $1,931
- Turalio (Drug) $130.51
- IBRANCE (Drug) $39.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Stanford
Sandhya Srinivas, Md, MD
Medical Oncology — Payments: $272,187
Ranjana Advani, Md, MD
Medical Oncology — Payments: $184,712
Kristen Ganjoo, Md, MD
Medical Oncology — Payments: $69,790
Heather Wakelee, Md, MD
Medical Oncology — Payments: $52,107
Arash Alizadeh, Md, Phd, MD, PHD
Medical Oncology — Payments: $46,821
Gregory Heestand, M.d, M.D
Medical Oncology — Payments: $34,424